AR038198A1 - Usos farmaceuticos de un inhibidor de cox-2 - Google Patents
Usos farmaceuticos de un inhibidor de cox-2Info
- Publication number
- AR038198A1 AR038198A1 ARP030100167A ARP030100167A AR038198A1 AR 038198 A1 AR038198 A1 AR 038198A1 AR P030100167 A ARP030100167 A AR P030100167A AR P030100167 A ARP030100167 A AR P030100167A AR 038198 A1 AR038198 A1 AR 038198A1
- Authority
- AR
- Argentina
- Prior art keywords
- methyl
- pharmaceutically acceptable
- cox
- inhibitor
- pharmaceutical uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Reivindicación 1: El uso de un compuesto de la fórmula (1), en donde: R es metilo o etilo, R1 es Cl o F, R2 es H o F; R3 es H, F, Cl, metilo, etilo, metoxilo, etoxilo o hidroxilo; R4 es H o F; y R5 es Cl, F, trifluorometilo o metilo; o una sal o éster de profármaco farmacéuticamente aceptable del mismo, en la preparación de un medicamento para utilizarse en el tratamiento de un desorden ocular mediado por angiogénesis. Reivindicación 4: El uso de acuerdo con la reivindicación 1, o el método de acuerdo con la reivindicación 2, o el paquete de acuerdo con la reivindicación 3, en donde el compuesto de la fórmula (1) es ácido 5-metil-2-(2'-cloro-6'-fluoroanilino)-fenilacético o una sal farmacéuticamente aceptable del mismo, o un éster de profármaco farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201520.4A GB0201520D0 (en) | 2002-01-23 | 2002-01-23 | Pharmaceutical uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038198A1 true AR038198A1 (es) | 2005-01-05 |
Family
ID=9929598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100167A AR038198A1 (es) | 2002-01-23 | 2003-01-21 | Usos farmaceuticos de un inhibidor de cox-2 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20050043410A1 (es) |
| EP (1) | EP1503746B1 (es) |
| JP (1) | JP2005515241A (es) |
| CN (1) | CN1283240C (es) |
| AR (1) | AR038198A1 (es) |
| AT (1) | ATE375154T1 (es) |
| BR (1) | BR0307013A (es) |
| CA (1) | CA2468811C (es) |
| CY (1) | CY1106994T1 (es) |
| DE (1) | DE60316792T2 (es) |
| DK (1) | DK1503746T3 (es) |
| ES (1) | ES2291641T3 (es) |
| GB (1) | GB0201520D0 (es) |
| MY (1) | MY145266A (es) |
| PT (1) | PT1503746E (es) |
| TW (1) | TWI280878B (es) |
| WO (1) | WO2003061645A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| WO2005049014A1 (en) * | 2003-11-18 | 2005-06-02 | Pharmacia Corporation | Cox-2 inhibitors for the treatment or prevention of diabetes-related ocular disorders |
| SG193209A1 (en) * | 2008-09-10 | 2013-09-30 | Genentech Inc | Methods for inhibiting ocular angiogenesis |
| MX2011012133A (es) * | 2009-05-15 | 2011-12-06 | Glaxosmithkline Llc | Uso de formacion de imagen termica para control de un proceso de fabricacion. |
| WO2019070917A1 (en) * | 2017-10-03 | 2019-04-11 | The Schepens Eye Research Institute, Inc. | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME |
| CN114652826B (zh) * | 2022-01-24 | 2022-10-14 | 景泽生物医药(合肥)有限公司 | 抗egfr抗体的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652762A (en) * | 1970-04-14 | 1972-03-28 | Ciba Geigy Corp | Pharmaceutical compositions and methods employing substituted derivatives of 2-anilinophenylacetic acids and esters |
| CO4960662A1 (es) * | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
| US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
| CA2362816C (en) * | 1999-12-08 | 2007-02-06 | Pharmacia Corporation | Valdecoxib compositions |
| AR030630A1 (es) * | 2000-09-11 | 2003-08-27 | Novartis Ag | Composiciones farmaceuticas |
| PE20030323A1 (es) * | 2001-08-31 | 2003-05-12 | Novartis Ag | Composicion farmaceutica |
| MXPA04006482A (es) * | 2002-01-07 | 2004-10-04 | Pharmacia Corp | Mezcla de farmacos con velocidad de disolucion mejorada. |
-
2002
- 2002-01-23 GB GBGB0201520.4A patent/GB0201520D0/en not_active Ceased
-
2003
- 2003-01-20 TW TW092101106A patent/TWI280878B/zh not_active IP Right Cessation
- 2003-01-21 AR ARP030100167A patent/AR038198A1/es unknown
- 2003-01-22 US US10/502,180 patent/US20050043410A1/en not_active Abandoned
- 2003-01-22 MY MYPI20030212A patent/MY145266A/en unknown
- 2003-01-22 ES ES03731699T patent/ES2291641T3/es not_active Expired - Lifetime
- 2003-01-22 JP JP2003561590A patent/JP2005515241A/ja active Pending
- 2003-01-22 AT AT03731699T patent/ATE375154T1/de active
- 2003-01-22 DE DE60316792T patent/DE60316792T2/de not_active Expired - Lifetime
- 2003-01-22 CN CNB038025833A patent/CN1283240C/zh not_active Expired - Fee Related
- 2003-01-22 PT PT03731699T patent/PT1503746E/pt unknown
- 2003-01-22 BR BR0307013-1A patent/BR0307013A/pt not_active Application Discontinuation
- 2003-01-22 DK DK03731699T patent/DK1503746T3/da active
- 2003-01-22 CA CA2468811A patent/CA2468811C/en not_active Expired - Fee Related
- 2003-01-22 WO PCT/EP2003/000612 patent/WO2003061645A1/en active IP Right Grant
- 2003-01-22 EP EP03731699A patent/EP1503746B1/en not_active Expired - Lifetime
-
2007
- 2007-11-08 CY CY20071101445T patent/CY1106994T1/el unknown
-
2009
- 2009-06-10 US US12/481,609 patent/US20090247638A1/en not_active Abandoned
-
2012
- 2012-08-24 US US13/593,959 patent/US20120322874A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR0307013A (pt) | 2004-11-03 |
| ES2291641T3 (es) | 2008-03-01 |
| DK1503746T3 (da) | 2008-02-04 |
| DE60316792T2 (de) | 2008-07-24 |
| EP1503746A1 (en) | 2005-02-09 |
| ATE375154T1 (de) | 2007-10-15 |
| JP2005515241A (ja) | 2005-05-26 |
| TW200302081A (en) | 2003-08-01 |
| US20050043410A1 (en) | 2005-02-24 |
| PT1503746E (pt) | 2008-01-10 |
| CY1106994T1 (el) | 2012-09-26 |
| US20090247638A1 (en) | 2009-10-01 |
| CA2468811A1 (en) | 2003-07-31 |
| TWI280878B (en) | 2007-05-11 |
| WO2003061645A1 (en) | 2003-07-31 |
| DE60316792D1 (de) | 2007-11-22 |
| CN1283240C (zh) | 2006-11-08 |
| GB0201520D0 (en) | 2002-03-13 |
| EP1503746B1 (en) | 2007-10-10 |
| CN1620288A (zh) | 2005-05-25 |
| CA2468811C (en) | 2011-08-09 |
| MY145266A (en) | 2012-01-13 |
| US20120322874A1 (en) | 2012-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR061846A1 (es) | Compuestos heteroaromaticos de azol inhibidores selectivos de la pde10a, composiciones farmaceuticas que los contienen y usos para tratar trastornos asociados al cns. | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| AR082825A2 (es) | Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios | |
| AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
| RS54438B1 (en) | PHARMACEUTICAL DOSAGE FORM CONTAINING 6`-FLUORO- (N-METHYL-OR N, N-DIMETHYL) - 4-PHENYL-4`, 9`-DIHYDRO-3`H-SPIRO [CYCLOHEXANE-1,1`-PIRANO [3,4, B] INDOL] -4-AMINE | |
| BR0115382A (pt) | Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica | |
| BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
| SV2003000633A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
| BR0315337A (pt) | Composto, formulação farmacêutica, e, método para tratar câncer | |
| AR039419A1 (es) | Compuesto de benzopiran-4-ona, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento | |
| AR034556A1 (es) | Un derivado de fenilalanina, una composicion farmaceutica que comprende al derivado de fenilalanina, el uso del derivado y proceso para preparar dicho derivado | |
| UY27740A1 (es) | Nuevos compuestos | |
| NO20045656L (no) | Oftalmologisk anvendelse av roflumilast for behandlingen av oyesykdommer | |
| ECSP055745A (es) | Derivados de 1-(4-bencil-piperazin-1-il)-3-fenil-propenona | |
| MA30821B1 (fr) | Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes | |
| AR051797A1 (es) | Derivados de hidantoina inhibidores de metaloproteinasas | |
| MXPA04010055A (es) | Derivados de tioxantina como inhibidores de mieloperoxidasa. | |
| AR014964A1 (es) | Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones | |
| AR035750A1 (es) | Uso de n- (piridinilamino) indoles para la preparacion de medicamentos para el tratamiento de enfermedades o trastornos desmielinizantes | |
| AR038198A1 (es) | Usos farmaceuticos de un inhibidor de cox-2 | |
| AR030630A1 (es) | Composiciones farmaceuticas | |
| HK1058515A1 (en) | Use of pamoic acid for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates. | |
| PE20050393A1 (es) | Compuestos de benzopirano para uso en el tratamiento y la prevencion de afecciones relacionadas con la inflamacion | |
| EA200800071A1 (ru) | Производные бензофуранила как ингибиторы 5-нт6-рецептора | |
| AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |